Popular Alzheimer’s drug now available in generic patch
The first generic version of Exelon (rivastigmine tartrate), a popular drug for treating mild to moderate dementia, appeared on the U.S. market this week, giving providers and seniors a more economical alternative to the branded drug. Rivastigmine is used to treat the cognitive issues associated with Alzheimer’s disease and Parkinson’s disease.
Swiss drug manufacturer Acino launched the drug in a transdermal patch form and in three doseage strengths. It is being sold in the United States by Acino’s licensing partner, Alvogen.
The generic rivastigmine patch has been used in the UK and parts of Europe for several years.
Pamela Tabar was editor-in-chief of I Advance Senior Care from 2013-2018. She has worked as a writer and editor for healthcare business media since 1998, including as News Editor of Healthcare Informatics. She has a master’s degree in journalism from Kent State University and a master’s degree in English from the University of York, England.
Topics: Alzheimer's/Dementia , Clinical